HSP90 is frequently overexpressed in various cancers, contributing to the stabilization and activity of numerous proteins involved in tumor growth and survival, making it a critical therapeutic target (Mahajan et al., 2024; Rastogi et al., 2024). This evidence concerns the gene HSP90AA1 and neoplasm.